The global short bowel syndrome market is expected to grow at a CAGR of around 6.3% during 2024-2033. This report on global short bowel syndrome market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global short bowel syndrome market by segmenting the market based on drug class, application and region. Also, detailed profiles of companies operating in the short bowel syndrome market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
• Increasing Acceptance of Short Bowel Syndrome Treatment
• Growing Prescriptions for the Gattex Therapy
• Strong Pipeline Drugs

Market Challenges
• Dangerous Side Effects Restrict Demand
• Changes in Splanchnic Perfusion

Historical & Forecast Period

Base Year: 2023
Historical Period: 2019-2023
Forecast Period: 2024-2033

Market by Drug Class
• Glucagon-like Peptide-2 (GLP-2)
• Growth Hormone
• Glutamine
• Others

Market by Application
• Hospitals
• Clinics

Market by Region
• Europe
o Germany
o United Kingdom
o France
o Italy
o Spain
o Russia
o Netherlands
o Rest of Europe
• North America
o United States
o Canada
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Rest of Asia Pacific
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
• Middle East & Africa
o Saudi Arabia
o Turkey
o Iran
o United Arab Emirates
o Rest of Middle East & Africa